Comment on: Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
S
S
Cooreman
A
A
Jeurissen
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001996:Bronchopneumonia / Q000188:drug therapy*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D008911:Minocycline / Q000008:administration & dosage / Q000031:analogs & derivatives; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D013754:Tetracyclines / Q000008:administration & dosage; D000078304:Tigecycline; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D013754:Tetracyclines; C087533:CL 331002; D000078304:Tigecycline; D008911:Minocycline